Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.92
+0.17 (2.87%)
Nov 21, 2024, 11:52 AM EST - Market open

Abeona Therapeutics Revenue

In the year 2023, Abeona Therapeutics had annual revenue of $3.50M with 147.52% growth.

Revenue (ttm)
$3.50M
Revenue Growth
+147.52%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
84
Market Cap
257.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.50M2.09M147.52%
Dec 31, 20221.41M-1.59M-52.87%
Dec 31, 20213.00M-7.00M-70.00%
Dec 31, 202010.00M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zynex 193.67M
Anika Therapeutics 164.17M
Poseida Therapeutics 150.86M
Lifecore Biomedical 128.44M
Eton Pharmaceuticals 34.68M
Fate Therapeutics 13.45M
Ocugen 4.70M
Revenue Rankings